Wistuba I - Search Results

1

Chemistry-First Approach for Nomination of Personalized Treatment in Lung Cancer.

McMillan EA, Ryu MJ, Diep CH, Mendiratta S, Clemenceau JR, Vaden RM, Kim JH, Motoyaji T, Covington KR, Peyton M, Huffman K, Wu X, Girard L, Sung Y, Chen PH, Mallipeddi PL, Lee JY, Hanson J, Voruganti S, Yu Y, Park S, Sudderth J, DeSevo C, Muzny DM, Doddapaneni H, Gazdar A, Gibbs RA, Hwang TH, Heymach JV, Wistuba I, Coombes KR, Williams NS, Wheeler DA, MacMillan JB, Deberardinis RJ, Roth MG, Posner BA, Minna JD, Kim HS, White MA. McMillan EA, et al. Among authors: wistuba i. Cell. 2018 May 3;173(4):864-878.e29. doi: 10.1016/j.cell.2018.03.028. Epub 2018 Apr 19. Cell. 2018. PMID: 29681454 Free PMC article.

2

FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.

Fong KM, Biesterveld EJ, Virmani A, Wistuba I, Sekido Y, Bader SA, Ahmadian M, Ong ST, Rassool FV, Zimmerman PV, Giaccone G, Gazdar AF, Minna JD. Fong KM, et al. Among authors: wistuba i. Cancer Res. 1997 Jun 1;57(11):2256-67. Cancer Res. 1997. PMID: 9187130

3

Clonality of combined tumors.

Huang J, Behrens C, Wistuba II, Gazdar AF, Jagirdar J. Huang J, et al. Among authors: wistuba ii. Arch Pathol Lab Med. 2002 Apr;126(4):437-41. doi: 10.5858/2002-126-0437-COCT. Arch Pathol Lab Med. 2002. PMID: 11900568 Free article.

4

Differential expression of FEZ1/LZTS1 gene in lung cancers and their cell cultures.

Toyooka S, Fukuyama Y, Wistuba II, Tockman MS, Minna JD, Gazdar AF. Toyooka S, et al. Among authors: wistuba ii. Clin Cancer Res. 2002 Jul;8(7):2292-7. Clin Cancer Res. 2002. PMID: 12114433

5

Smoking molecular damage in bronchial epithelium.

Wistuba II, Mao L, Gazdar AF. Wistuba II, et al. Oncogene. 2002 Oct 21;21(48):7298-306. doi: 10.1038/sj.onc.1205806. Oncogene. 2002. PMID: 12379874 Review.

6

Characteristic genetic alterations in lung cancer.

Wistuba II, Gazdar AF. Wistuba II, et al. Methods Mol Med. 2003;74:3-28. doi: 10.1385/1-59259-323-2:03. Methods Mol Med. 2003. PMID: 12415683 Review.

7

Gallbladder cancer: lessons from a rare tumour.

Wistuba II, Gazdar AF. Wistuba II, et al. Nat Rev Cancer. 2004 Sep;4(9):695-706. doi: 10.1038/nrc1429. Nat Rev Cancer. 2004. PMID: 15343276 Review.

8

Aberrant promoter hypermethylation of multiple genes in gallbladder carcinoma and chronic cholecystitis.

Takahashi T, Shivapurkar N, Riquelme E, Shigematsu H, Reddy J, Suzuki M, Miyajima K, Zhou X, Bekele BN, Gazdar AF, Wistuba II. Takahashi T, et al. Among authors: wistuba ii. Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6126-33. doi: 10.1158/1078-0432.CCR-04-0579. Clin Cancer Res. 2004. PMID: 15447999

9

Aberrant methylation of Reprimo in human malignancies.

Takahashi T, Suzuki M, Shigematsu H, Shivapurkar N, Echebiri C, Nomura M, Stastny V, Augustus M, Wu CW, Wistuba II, Meltzer SJ, Gazdar AF. Takahashi T, et al. Among authors: wistuba ii. Int J Cancer. 2005 Jul 1;115(4):503-10. doi: 10.1002/ijc.20910. Int J Cancer. 2005. PMID: 15700311 Free article. Retracted.

10

Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers.

Shigematsu H, Lin L, Takahashi T, Nomura M, Suzuki M, Wistuba II, Fong KM, Lee H, Toyooka S, Shimizu N, Fujisawa T, Feng Z, Roth JA, Herz J, Minna JD, Gazdar AF. Shigematsu H, et al. Among authors: wistuba ii. J Natl Cancer Inst. 2005 Mar 2;97(5):339-46. doi: 10.1093/jnci/dji055. J Natl Cancer Inst. 2005. PMID: 15741570

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

825 results

Search Page